Enara Bio Enara Bio (formerly known as Ervaxx) is a biotech company specializing in the use of Dark Antigens to deliver vaccines and other immunotherapies for treating and preventing cancer. | ![]() ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. | ![]() Aeglea Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics. | |
Founding Date | Founding Date 2016 | Founding Date 1981 | Founding Date 2013 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Oxford, GB HQ London, GB London, GB Oxford, GB | Locations Waltham, US HQ | Locations Austin, US HQ |
Employees | Employees 622% increase | Employees 277161% increase | Employees 65117% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 8.7 b | Valuation ($) 48.6 m |
Financial | |||
Net income | Net income N/A | Net income ($222.9m) (FY, 2022) | Net income ($155.2m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 17.5m | Total funding raised $ 56m | Total funding raised N/A |

ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.
View company
Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics.
View company